Grant: A phase III, randomized, double-blind, active-controlled, parallel-group study, conducted under in-house building conditions, to examine the safety, tolerability, and efficacy of a single dose of intravenous MK-0517 for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated wtih Cisplatin chemotheray
| Project Title |
A phase III, randomized, double-blind, active-controlled, parallel-group study, conducted under in-house building conditions, to examine the safety, tolerability, and efficacy of a single dose of intravenous MK-0517 for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated wtih Cisplatin chemotheray
|
|---|---|
| Principal Investigator | Ho, James Chung Man (Principal investigator) |
| Co-Investigator(s) |
Dr Wang Julie Kwan Ling
(Co-Investigator)
Dr Lam David Chi Leung (Co-Investigator) Dr Wong Matthew King Yan (Co-Investigator) Dr Lam Jamie Chung Mei (Co-Investigator) |
| Funding Year |
2008/2009
|
| Amount |
79444
|
| Panel | Medicine |
| Start Date |
01-06-2008
|
| Expected Completion |
30-06-2009
|
| Status |
On-going
|
| Keywords | chemotherapy-induced nausea and vomiting |
| Discipline | Respiration, Cancer |
| Grant Type/Funding Scheme | Pharmaceutical Industry - General Award |
| Duration |
13
|
[Coming Soon]